TickerFactsScreenerDevelopers

Immunovant, Inc. (IMVT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $52.0K2020: $31.0K2021: $210.0K2022: $254.0K2023: $197.0K2024: $360.0K2025: $759.0K2026: $8.0K$8.0K
2019Capital Expenditures (USD)2026
Fiscal YearCapital ExpendituresChange YoY
2026$8.0K-98.9%
2025$759.0K+110.8%
2024$360.0K+82.7%
2023$197.0K-22.4%
2022$254.0K+21.0%
2021$210.0K+577.4%
2020$31.0K-40.4%
2019$52.0K—